EP3716995A4 - Polythérapie et prophylaxie contre des infections du tractus génital - Google Patents

Polythérapie et prophylaxie contre des infections du tractus génital Download PDF

Info

Publication number
EP3716995A4
EP3716995A4 EP18884342.9A EP18884342A EP3716995A4 EP 3716995 A4 EP3716995 A4 EP 3716995A4 EP 18884342 A EP18884342 A EP 18884342A EP 3716995 A4 EP3716995 A4 EP 3716995A4
Authority
EP
European Patent Office
Prior art keywords
prophylaxis
tract infections
combined therapy
genital tract
genital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18884342.9A
Other languages
German (de)
English (en)
Other versions
EP3716995A1 (fr
Inventor
Michael W. Russell
Yingru LIU
Nejat K. Egilmez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Original Assignee
Research Foundation of State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/824,700 external-priority patent/US20180071379A1/en
Priority claimed from US16/138,526 external-priority patent/US20190008941A1/en
Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York
Publication of EP3716995A1 publication Critical patent/EP3716995A1/fr
Publication of EP3716995A4 publication Critical patent/EP3716995A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP18884342.9A 2017-11-28 2018-11-27 Polythérapie et prophylaxie contre des infections du tractus génital Withdrawn EP3716995A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/824,700 US20180071379A1 (en) 2012-05-29 2017-11-28 Combined therapy and prophylaxis for genital tract infections
US16/138,526 US20190008941A1 (en) 2012-05-29 2018-09-21 Combined therapy and prophylaxis for genital tract infections
PCT/US2018/062590 WO2019108528A1 (fr) 2017-11-28 2018-11-27 Polythérapie et prophylaxie contre des infections du tractus génital

Publications (2)

Publication Number Publication Date
EP3716995A1 EP3716995A1 (fr) 2020-10-07
EP3716995A4 true EP3716995A4 (fr) 2021-08-25

Family

ID=66665780

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18884342.9A Withdrawn EP3716995A4 (fr) 2017-11-28 2018-11-27 Polythérapie et prophylaxie contre des infections du tractus génital

Country Status (7)

Country Link
EP (1) EP3716995A4 (fr)
JP (1) JP2021504478A (fr)
CN (1) CN111698998A (fr)
AU (1) AU2018375133A1 (fr)
CA (1) CA3083741A1 (fr)
MX (1) MX2020007237A (fr)
WO (1) WO2019108528A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110123491A1 (en) * 2007-10-01 2011-05-26 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
US20150139941A1 (en) * 2012-05-29 2015-05-21 The Research Foundation for the The State University of New York Combined therapy and prophylaxis for genital tract infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1416352B (zh) * 2000-01-17 2011-05-25 启龙股份公司 含有脑膜炎奈瑟球菌b血清群外膜蛋白质的外膜囊(omv)疫苗

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110123491A1 (en) * 2007-10-01 2011-05-26 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
US20150139941A1 (en) * 2012-05-29 2015-05-21 The Research Foundation for the The State University of New York Combined therapy and prophylaxis for genital tract infections

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PLANTE MARTIN ET AL: "Intranasal Immunization with Gonococcal Outer Membrane Preparations Reduces the Duration of Vaginal Colonization of Mice by Neisseria gonorrhoeae", THE JOURNAL OF INFECTIOUS DISEASES, 1 September 2000 (2000-09-01), Chicago, IL, pages 848 - 855, XP055823874, Retrieved from the Internet <URL:https://watermark.silverchair.com/182-3-848.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAtEwggLNBgkqhkiG9w0BBwagggK-MIICugIBADCCArMGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMOX-7exfidimHRLOgAgEQgIIChNGw8JLBFHq3jMTS_aAGl1sKsnrRifVlXUlzRlDvqZin59ILSuj0Cf4n73tE0otzOJ3AewNN4cNQ98uBPvLfafwq9X> [retrieved on 20210713] *
See also references of WO2019108528A1 *
YINGRU LIU ET AL: "Enhancement of Adaptive Immunity to Neisseria gonorrhoeae by Local Intravaginal Administration of Microencapsulated Interleukin 12", THE JOURNAL OF INFECTIOUS DISEASES, INFECTIOUS DISEASES SOCIETY OF AMERICA, US, vol. 208, no. 11, 1 December 2013 (2013-12-01), pages 1821 - 1829, XP002752441, ISSN: 1537-6613, [retrieved on 20130918], DOI: 10.1093/INFDIS/JIT354 *

Also Published As

Publication number Publication date
WO2019108528A1 (fr) 2019-06-06
JP2021504478A (ja) 2021-02-15
EP3716995A1 (fr) 2020-10-07
MX2020007237A (es) 2020-09-25
AU2018375133A1 (en) 2020-06-18
CA3083741A1 (fr) 2019-06-19
CN111698998A (zh) 2020-09-22

Similar Documents

Publication Publication Date Title
EP3732195A4 (fr) Agent thérapeutique induisant une cytotoxicité
EP3352719A4 (fr) Fauteuil roulant améliorant la mobilité
EP3619238A4 (fr) Agent thérapeutique induisant une cytotoxicité
EP3280722B8 (fr) Peptides antimicrobiens et leur utilisation pour le traitement d&#39;infections locales
EP3735463A4 (fr) Agent thérapeutique induisant une cytotoxicité
EP3655404A4 (fr) Composés et leur utilisation pour le traitement d&#39;infections microbiennes
EP3346142A4 (fr) Actionneur et dispositif d&#39;assistante au corps
LT3820856T (lt) C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti
IL250596A0 (en) The composition for the treatment and prevention of urinary tract infections
EP3426671A4 (fr) Composés et compositions pour le traitement d&#39;infections
PT3102218T (pt) Conjunto de dobradiças para uma porta de vidro isolado
HUE055738T2 (hu) Új MEK-inhibitor vírus- és baktérium-fertõzések kezelésére
EP3866601A4 (fr) Organosilanes pour le traitement d&#39;infections
EP3411367A4 (fr) Compositions et méthodes de traitement d&#39;infections bactériennes
EP3466745A4 (fr) Corps mobile et système de corps mobile
EP3120852A4 (fr) Agent prophylactique et/ou thérapeutique destiné à des maladies immunitaires
EP3193946A4 (fr) Analogues de saccharide et agents pour le diagnostic et la thérapie d&#39;infections bactériennes
EP3581204A4 (fr) Agent préventif et/ou thérapeutique contre des maladies infectieuses ou inflammatoires
EP3668526A4 (fr) Compositions de traitement d&#39;infections de membranes de la peau et des muqueuses
EP3487585A4 (fr) Isolement de l&#39;oléocanthal et traitement du cancer
EP3362062A4 (fr) Compositions et procédés pour traiter des infections du tractus urinaire
HUE045242T2 (hu) Vírusfertõzések megelõzésére és terápiájára szánt ágens
EP3285796A4 (fr) Agents photosensibles et de rétablissement de la sensibilité aux antibiotiques
EP3343942A4 (fr) Système de haut-parleur pour un corps mobile et corps mobile
EP3716995A4 (fr) Polythérapie et prophylaxie contre des infections du tractus génital

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200625

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40038442

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20210722

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/20 20060101AFI20210719BHEP

Ipc: A61P 31/04 20060101ALI20210719BHEP

Ipc: A61K 39/00 20060101ALI20210719BHEP

Ipc: A61K 39/095 20060101ALI20210719BHEP

Ipc: A61K 9/00 20060101ALI20210719BHEP

Ipc: A61K 9/16 20060101ALI20210719BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220222